Afuco™ Anti-Human CLEC12A ADCC Therapeutic Antibody, ADCC Enhanced
Anti-CLEC12A ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is an antibodiy that specifically bind to human CLL-1, in particular to the extracellular domain of a CLL-1 expressing cell. The CLL-1 antibodies can inhibit cancer cell growth (proliferation and/or engraftment) and thus can be considered chemotherapeutic agents alone.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-161CL |
| Pricing | Inquiry |
| Host | Human |
| Target | CLEC12A |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |